Fundraising Fox
🦊/People
Sign in

Joris De Maeyer

Investor

Investor at Bioqube Ventures

Antwerp, Belgium

Writes $100K – $5M checks · typically $1.5M

Find your path to Joris

374 people in our graph share verified history with Joris — schools, employers, funds. One of them is your warm intro.

Teresa ChanunlockedJoris: together at Johnson & Johnson (2002–2004)
×2Joris: together at KU Leuven
×6Joris: together at Johnson & Johnson
×3Joris: together at Ghent University

About

Joris joined Bioqube Ventures in 2016 as Investment Director before becoming an Entrepreneur in Residence, advising the investment team and portfolio companies. He brings over 20 years of pharma and biotech experience, including roles as CEO/CSO of Facio Therapeutics and senior R&D positions at Johnson & Johnson, Movetis, and Shire. He holds a PhD in Medical Sciences from Ghent University and an MSc in Bioengineering from KU Leuven.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. Temmune TherapeuticsChief Executive Officercurrent2026 — present
  2. Temmune TherapeuticsChief Operations Officer - COO2024 — 2025
  3. Invigo TherapeuticsFoundercurrent2023 — presentBelgium
  4. Bioqube VenturesExecutive in Residencecurrent2023 — present
  5. Bioqube VenturesInvestment Director2020 — 2023
  6. Bioqube VenturesVenture Coach2016 — 2020
  7. Anavo Therapeutics BVBoard Observercurrent2021 — present
  8. LIFE of SCIManaging Director - Life Science Consultingcurrent2013 — presentBelgium
  9. Facio TherapiesChief Executive Officer2021 — 2022
  10. Facio TherapiesActing Chief Executive Officer2021
  11. Facio TherapiesChief Scientific Officer2019 — 2021
  12. Facio TherapiesDirector R&D2014 — 2019
  13. ShireDirector Discovery2011 — 2013Belgium
  14. MovetisManager Drug Discovery & Development2007 — 2010Belgium
  15. Johnson & JohnsonScientist Drug Discovery2002 — 2006Belgium
  16. Johnson & JohnsonSenior Associate Preclinical Development (GLP DMPK TOX QA)2001 — 2002Belgium
  17. Vlaamse Milieumaatschappij - VMMAuditor Surface Water Monitoring Network2001
  18. KU LeuvenResearch associate2000 — 2001

Skills & more

Lifesciences15Pharmacology34Drug Discovery31Biotechnology18Drug Development23Pharmaceutical Industry10CRO6R&D5Life Sciences7

From Joris's professional profile.

Colleagues at Bioqube Ventures

Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Janine Schuurman
Senior Advisor at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures

Network4

Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures

Investors connected to Joris in public investor directories — a warm-intro map.

Frequently asked questions

Who is Joris De Maeyer?
Joris joined Bioqube Ventures in 2016 as Investment Director before becoming an Entrepreneur in Residence, advising the investment team and portfolio companies. He brings over 20 years of pharma and biotech experience, including roles as CEO/CSO of Facio Therapeutics and senior R&D positions at Johnson & Johnson, Movetis, and Shire. He holds a PhD in Medical Sciences from Ghent University and an MSc in Bioengineering from KU Leuven.
Where does Joris De Maeyer work?
Joris De Maeyer is Investor at Bioqube Ventures.
What does Joris De Maeyer invest in?
Joris De Maeyer invests in Biotech.
What check size does Joris De Maeyer write?
Joris De Maeyer typically writes checks of $100K – $5M.
Where did Joris De Maeyer go to school?
Joris De Maeyer studied at Ghent University (PhD, Medical Sciences); KU Leuven (Master's degree, Master in Engineering in Cell and Gene Biotechnology); Vrije Universiteit Brussel (Business and Biotechnology).

Same school

Shared employers